Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Oramed Pharmaceuticals Inc ORMP

Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:ORMP)

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

GlobeNewswire March 19, 2024

Oramed Letter to Shareholders

PR Newswire February 20, 2024

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

PR Newswire September 22, 2023

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company

PR Newswire September 21, 2023

Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.

GlobeNewswire September 21, 2023

Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder

GlobeNewswire September 13, 2023

Oramed to Present at the 83rd American Diabetes Association Conference

PR Newswire June 20, 2023

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

PR Newswire May 18, 2023

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China

PR Newswire May 15, 2023

Opinion & Analysis (NDAQ:ORMP)

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016

Bullboard Posts (NDAQ:ORMP)

Rising now?

What's the big deal?  Rising on no news?  Testing underway but has been for some time  and no results before H2/20.
zalmonella - February 17, 2021

Is something BIG

Is this calm before the storm or am I just dreaming
gktrader - August 13, 2007

Oramed Pharm Inc.

Oramed Pharmaceuticals Announces Maiden Year Progress Report 2007-03-13 13:51 ET - News Release JERUSALEM, March 13 /CNW...
darthtrader77 - March 29, 2007